Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular Genetics and Metabolism

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ymgme.2010.11.158PMID 21147011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phenylalanine hydroxylase deficiency

  2011cited by this paper
• Challenges and Pitfalls in the Management of Phenylketonuria

  2010cited by this paper
• Phenylketonuria.

  2010cited by this paper
• Significance of genotype in tetrahydrobiopterin-responsive phenylketonuria

  2009cited by this paper
• Biochemical characterization of mutant phenylalanine hydroxylase enzymes and correlation with clinical presentation in hyperphenylalaninaemic patients

  2009cited by this paper
• Optimizing the use of sapropterin (BH(4)) in the management of phenylketonuria.

  2009cited by this paper
• A limited spectrum of phenylalanine hydroxylase mutations is observed in phenylketonuria patients in western Poland and implications for treatment with 6R tetrahydrobiopterin

  2009cited by this paper
• Effect of BH4 supplementation on phenylalanine tolerance

  2009cited by this paper
• Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability.

  2008cited by this paper
• Molecular genetics of tetrahydrobiopterin‐responsive phenylalanine hydroxylase deficiency

  2008cited by this paper
• The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study

  2007cited by this paper
• Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study.

  2007cited by this paper
• Assessment of tetrahydrobiopterin responsiveness in Turkish hyperphenylalaninemic patients.

  2007cited by this paper
• Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria.

  2007cited by this paper
• Mutations in the phenylalanine hydroxylase gene identified in 95 patients with phenylketonuria using novel systems of mutation scanning and specific genotyping based upon thermal melt profiles.

  2007cited by this paper
• Mutations in the BH4‐metabolizing genes GTP cyclohydrolase I, 6‐pyruvoyl‐tetrahydropterin synthase, sepiapterin reductase, carbinolamine‐4a‐dehydratase, and dihydropteridine reductase

  2006cited by this paper
• The activity of wild-type and mutant phenylalanine hydroxylase and its regulation by phenylalanine and tetrahydrobiopterin at physiological and pathological concentrations: an isothermal titration calorimetry study.

  2005cited by this paper
• Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria.

  2005cited by this paper
• Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin.

  2005cited by this paper
• Long-Term Treatment and Diagnosis of Tetrahydrobiopterin-Responsive Hyperphenylalaninemia with a Mutant Phenylalanine Hydroxylase Gene

  2004cited by this paper
• The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.

  2004cited by this paper
• Phenylketonuria mutations in Europe

  2003cited by this paper
• PAHdb 2003: What a locus‐specific knowledgebase can do

  2003cited by this paper
• High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1,919 patients observed from 1988 to 2002.

  2002cited by this paper
• Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria.

  2002cited by this paper
• Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency.

  2001cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Tetrahydrobiopterin biosynthesis, regeneration and functions.

  2000cited by this paper
• Molecular basis of mild hyperphenylalaninaemia in Turkey

  2000cited by this paper
• Phenylketonuria mutations in Germany

  1999cited by this paper
• Optimization of an automated DNA purification protocol for neonatal screening.

  1999cited by this paper
• Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.

  1999cited by this paper
• Mutation analysis in Turkish phenylketonuria patients.

  1993cited by this paper
• Review of neonatal screening programme for phenylketonuria.

  1991cited by this paper
• Diagnosis of phenylalanine hydroxylase deficiency (phenylketonuria).

  1982cited by this paper
• Determination of Phenylalanine Hydroxylase Activity in Patients with Phenylketonuria and Hyperphenylalaninemia

  1975cited by this paper
• Letter: Pseudohyperkalaemia in acute myeloid leukaemia.

  1974cited by this paper
• Phenylalanine-hydroxylase activity in hyperphenylalaninaemia.

  1967cited by this paper

• Genotype-phenotype correlations in phenylketonuria: PAH variants and BH4 responsiveness for treatment design.

  2026cites this paper
• The clinical utility of short-term protein substitute use during intercurrent illness in BH4-responsive phenylketonuria.

  2025cites this paper
• High‐Resolution Haplotyping of the PAH Gene Enables Early Gestation Noninvasive Prenatal Diagnosis of Phenylketonuria and Evolution Analysis of Recurrent Pathogenic Variations

  2024cites this paper
• Assessment of Pathogenic Variants in the PAH Gene and Genotype–Phenotype Correlation in Phenylketonuria Patients from Turkey

  2024cites this paper
• Delays in Newborn Screening for Phenylketonuria from Birth to Diagnosis and Factors Affecting This

  2024cites this paper
• Comprehensive analyses of phenylalanine hydroxylase variants and phenotypic characteristics of patients in the eastern region of Türkiye

  2024cites this paper
• Emerging biosensors in Phenylketonuria.

  2024cites this paper
• The effects of a self-learning package on mothers' knowledge and practices towards caring for their children with phenylketonuria

  2023cites this paper
• Predictors of eventual requirement of phenylalanine-restricted diet in young infants with phenylalanine hydroxylase deficiency initially managed with sapropterin monotherapy.

  2023cites this paper
• Mutational landscape of phenylketonuria in Iran

  2023cites this paper
• Classical phenylketonuria presenting as maternal PKU syndrome in the offspring of an intellectually normal woman

  2023cites this paper
• Spectrum of PAH gene mutations and genotype–phenotype correlation in patients with phenylalanine hydroxylase deficiency from Turkey

  2022cites this paper
• Genetic etiology and clinical challenges of phenylketonuria

  2022influential citation
• An update of the mutation spectrum of phenylalanine hydroxylase (PAH) gene in the population of Turkey

  2022cites this paper
• Endoplasmic reticulum stress in leukocytes from phenylketonuric patients

  2021cites this paper
• Amino acid metabolism disorders and PAH gene mutations in Southeastern Anatolia Region

  2021influential citation
• Spectrum of PAH gene mutations in 1547 phenylketonuria patients from Iran: a comprehensive systematic review

  2021cites this paper
• Production of low protein and gluten-free cookies for phenylketonuria (PKU) and/or celiac patients

  2021cites this paper
• Phenylketonuria Diagnosis by Massive Parallel Sequencing and Genotype-Phenotype Association in Brazilian Patients

  2020cites this paper
• Tetrahydrobiopterin in phenylketonuria: Who can benefit?

  2020cites this paper
• Genetic variants of the phenylalanine hydroxylase gene in patients with phenylketonuria in the northeast of Iran

  2020cites this paper
• Genotypes of 2579 patients with phenylketonuria reveal a high rate of BH4 non-responders in Russia

  2019cites this paper
• Investigation of exon 4 mutations of phenylalanine hydroxylase gene in phenylketonuria patients in Guilan Province using PCR-sequencing

  2019cites this paper
• Molecular-Genetic Study of Phenylketonuria in Patients from Georgia

  2019cites this paper
• The molecular epidemiology of hyperphenylalaninemia in Uygur population: incidence from newborn screening and mutational spectra.

  2019cites this paper
• International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria.

  2019cites this paper
• Mutation spectrum of PAH gene in phenylketonuria patients in Northwest China: identification of twenty novel variants

  2019cites this paper
• Allelic phenotype values: a model for genotype-based phenotype prediction in phenylketonuria

  2018cites this paper
• Analyse der strukturchemischen Grundlagen der Wechselwirkungen zwischen der Phenylalaninhydroxylase und ihrem natürlichen Kofaktor Tetrahydrobiopterin

  2018cites this paper
• Investigation of exon 4 mutations of phenylalanine hydroxylase gene in phenylketonuria patients in Guilan Province using PCR-sequencing

  2018cites this paper
• Classification of cerebral microbleeds based on fully-optimized convolutional neural network

  2018cites this paper
• Genotyping of patients with phenylketonuria from different regions of Russia for determining BH4 responsiveness

  2017cites this paper
• Mutation Analysis in Classical Phenylketonuria Patients Followed by Detecting Haplotypes Linked to Some PAH Mutations.

  2017cites this paper
• Spectrum of PAH gene variants among a population of Han Chinese patients with phenylketonuria from northern China

  2017cites this paper
• Aminoacidopathies: Prevalence, Etiology, Screening, and Treatment Options

  2017cites this paper
• Molecular assessment and bioinformatic analysis of two common mutations of phenylalanine hydroxylase (PAH) gene by HRM

  2017cites this paper
• Year : 2011 Diagnosis , classification , and genetics of phenylketonuria and tetrahydrobiopterin ( BH 4 ) deficiencies

  2017cites this paper
• Comparative Analysis of Phenylalanine Hydroxylase Mutations Spectrum in Novosibirsk and Kemerovo regions of Western Siberia, Russia

  2016cites this paper
• Successful Linkage Analysis in Classical Phenylketonuria Families Followed by Direct Sequencing and Mutation Detection.

  2016cites this paper
• Mutational and phenotypical spectrum of phenylalanine hydroxylase deficiency in Denmark

  2016influential citation
• Co-expression of phenylalanine hydroxylase variants and effects of interallelic complementation on in vitro enzyme activity and genotype-phenotype correlation.

  2016cites this paper
• A novel common large genomic deletion and two new missense mutations identified in the Romanian phenylketonuria population.

  2016cites this paper
• Molecular mechanisms of PAH function in response to phenylalanine and tetrahydrobiopterin binding

  2016influential citation
• Molecular characterisation of phenylketonuria in a Chinese mainland population using next-generation sequencing

  2015cites this paper
• Phenylalanine hydroxylase deficiency in Mexico: genotype–phenotype correlations, BH4 responsiveness and evidence of a founder effect

  2015cites this paper
• Genotype-phenotype associations in French patients with phenylketonuria and importance of genotype for full assessment of tetrahydrobiopterin responsiveness

  2015cites this paper
• Correlation between genotype and the tetrahydrobiopterin-responsive phenotype in Chinese patients with phenylketonuria

  2015cites this paper
• Phenylalanine hydroxylase deficiency in south Italy: Genotype-phenotype correlations, identification of a novel mutant PAH allele and prediction of BH4 responsiveness.

  2015cites this paper
• Mapping the functional landscape of frequent phenylalanine hydroxylase (PAH) genotypes promotes personalised medicine in phenylketonuria

  2015cites this paper
• Phenylketonuria Scientific Review Conference: state of the science and future research needs.

  2014cites this paper
• Targeting specific nutrient deficiencies in protein-restricted diets: some practical facts in PKU dietary management.

  2014cites this paper
• Molecular genetics and diagnosis of phenylketonuria: state of the art

  2014cites this paper
• Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators

  2014cites this paper
• Molecular genetics and diagnosis of phenylketonuria : state of the art Expert

  2014cites this paper
• Undiagnosed phenylketonuria in parents of phenylketonuric patients, is it worthwhile to be checked?

  2013cites this paper
• Molecular Characteristics, Phenotypic Diversity and Genotype-Estimated Therapeutic Responsiveness of Serbian Patients with Phenylketonuria / MOLEKULARNE KARAKTERISTIKE, FENOTIPSKA RAZNOLIKOST I PROCENA ODGOVORA NA TERAPIJU ZASNOVANA NA GENOTIPU KOD SRPSKIH PACIJENATA SA FENILKETONURIJOM

  2013cites this paper
• Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias

  2013cites this paper
• Molecular epidemiology and genotype–phenotype correlation in phenylketonuria patients from South Spain

  2013cites this paper
• Phenylalanine hydroxylase deficiency in the Slovak population: genotype-phenotype correlations and genotype-based predictions of BH4-responsiveness.

  2013cites this paper
• Testing for Tetrahydrobiopterin Responsiveness in Patients with Hyperphenylalaninemia due to Phenylalanine Hydroxylase Deficiency

  2013cites this paper
• PHENOTYPIC DIVERSITY AND GENOTYPE-ESTIMATED THERAPEUTIC RESPONSIVENESS OF SERBIAN PATIENTS WITH PHENYLKETONURIA

  2013cites this paper
• Spectrum of mutations in Lebanese patients with phenylalanine hydroxylase deficiency.

  2013cites this paper
• Tetrahydrobiopterin, its Mode of Action on Phenylalanine Hydroxylase, and Importance of Genotypes for Pharmacological Therapy of Phenylketonuria

  2013influential citation
• Molecular Genetics and Genotype-Based Estimation of BH4-Responsiveness in Serbian PKU Patients: Spotlight on Phenotypic Implications of p.L48S.

  2013influential citation
• Successful Live Birth following Preimplantation Genetic Diagnosis for Phenylketonuria in Day 3 Embryos by Specific Mutation Analysis and Elective Single Embryo Transfer.

  2013cites this paper
• The Molecular Bases of Phenylketonuria (PKU) in New South Wales, Australia: Mutation Profile and Correlation with Tetrahydrobiopterin (BH4) Responsiveness.

  2013cites this paper
• Long-term Follow-up and Outcome of Phenylketonuria Patients on Sapropterin: A Retrospective Study

  2013cites this paper
• JIMD Reports – Case and Research Reports, 2012/6

  2013cites this paper
• A preliminary mutation analysis of phenylketonuria in southwest Iran.

  2013influential citation
• Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype

  2013cites this paper
• The spectrum of mutations identified in Cypriot patients with phenylalanine hydroxylase deficiency detected through neonatal screening.

  2012cites this paper
• Utility of phenylalanine hydroxylase genotype for tetrahydrobiopterin responsiveness classification in patients with phenylketonuria.

  2012cites this paper
• Five novel mutations and two large deletions in a population analysis of the phenylalanine hydroxylase gene.

  2012cites this paper
• Quantification of phenylalanine hydroxylase activity by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry.

  2012cites this paper
• University of Southern Denmark Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable-Molecular pathology of mutations in PAH exon 11 Heintz,

  2012cites this paper
• The mechanism of BH4‐responsive hyperphenylalaninemia—As it occurs in the ENU1/2 genetic mouse model

  2012cites this paper
• JIMD Reports - Case and Research Reports, 2012/2

  2012cites this paper
• Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: molecular pathology of mutations in PAH exon 11.

  2012influential citation
• Update on the treatment of phenylketonuria: long-term safety and efficacy of sapropterin dihydrochloride

  2012cites this paper
• Identification of Mutations Underlying 20 Inborn Errors of Metabolism in the United Arab Emirates Population

  2012cites this paper
• Assessment of tetrahydrobiopterin (BH(4))-responsiveness and spontaneous phenylalanine reduction in a phenylalanine hydroxylase deficiency population.

  2012influential citation
• Chaperone-like therapy with tetrahydrobiopterin in clinical trials for phenylketonuria: is genotype a predictor of response?

  2012cites this paper
• The spectrum of phenylketonuria genotypes in the Armenian population: identification of three novel mutant PAH alleles.

  2011cites this paper
• The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response.

  2011cites this paper
• Phenotyping and treatment of phenylketonuria – Authors' reply

  2011cites this paper
• Tetrahydrobiopterin: biochemistry and pathophysiology.

  2011cites this paper
• Phenylalanine hydroxylase deficiency: molecular epidemiology and predictable BH4-responsiveness in South Portugal PKU patients.

  2011cites this paper
• Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies.

  2011cites this paper